Mirum Pharmaceuticals, Inc. MIRM Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s income tax?
- Mirum Pharmaceuticals, Inc. (MIRM) reported income tax of $475K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s income tax changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s income tax decreased by 53.8% year-over-year, from $1.03M to $475K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s income tax?
- Over 3 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s income tax has grown at a 274.0% compound annual growth rate (CAGR), from $37K to $1.94M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.